IMS HEALTH, INC.

Inactive Instrument

IMS Health, Inc. Stock

Stocks

US4499341083

Biotechnology & Medical Research

End-of-day quote NYSE
- ^USD	-

Press Releases: IMS Health, Inc.

23/02/10	IMS HEALTH USD : Standard & Poor's Announces Changes to U.S. Indices	PR
30/11/-1	Ims Health Inc. : IMS to Present at the Bear Stearns Healthcare Conference on September 11 at 7:10 a.m. and 2:30 p.m. ET	BU
30/11/-1	Ims Health Inc. : IMS to Present at the Thomas Weisel Partners Conference on September 6 at 3:15 p.m. EDT	BU
30/11/-1	Ims Health Inc. : IMS Health Names Kevin Knightly Senior VP, Business Line Management; Adel Al-Saleh Appointed President, Europe, Middle East and Africa	BU
30/11/-1	Ims Health Inc. : IMS Health Delivers 11 Percent Revenue and Operating Income Growth in Second Quarter	BU

More press releases

News in other languages: IMS Health, Inc.

25/08/16	'WiWo': GfK-Mehrheitseigner erwägen Verkauf
25/08/16	KORREKTUR/'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
25/08/16	'WiWo': Mehrheitseigner des Marktforschers GfK prüft Optionen
08/10/09	IMS HEALTH USD : IMS relève ses prévisions de ventes pharmaceutiques mondiales
30/11/-1	Ims Health Inc. : IMS Health prévoit une croissance de 5 à 6 pour cent du marché pharmaceutique mondial en 2007

Managers and Directors: IMS Health, Inc.

Manager	Title	Age	Since
Ari Bousbib CEO	Chief Executive Officer	64	01/10/2016
Jon Resnick PSD	President	53	01/07/2019
James Berkshire COO	Chief Operating Officer	53	01/07/2017

Director	Title	Age	Since
Ari Bousbib CHM	Chairman	64	01/10/2016

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	WUXI APPTEC CO., LTD.	+0.65%	-3.36%	+36.98%	+60.50%	63.48B
	ARGENX SE	+1.76%	+1.27%	+11.82%	+81.21%	54.55B
	LONZA GROUP AG	-0.94%	+0.99%	+10.45%	+100.19%	53.59B
	IQVIA HOLDINGS INC.	+2.76%	+0.87%	+27.92%	+55.07%	44.75B
	BEONE MEDICINES AG	+2.00%	-3.39%	+17.83%	+119.04%	41.62B
	REVOLUTION MEDICINES, INC.	+1.34%	-2.86%	+224.43%	+914.08%	39.91B
	CELLTRION, INC.	+0.64%	-3.95%	+11.15%	+45.57%	32.47B
	GENMAB A/S	+29.06%	+47.63%	+107.12%	+92.73%	26.7B
	WUXI BIOLOGICS (CAYMAN) INC.	+3.72%	-6.23%	+26.01%	-2.99%	23.36B
	Average	+4.55%	-0.42%	+52.63%	+162.82%	42.27B
	Weighted average by Cap.	+3.23%	-0.29%	+48.19%	+161.47%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!